feed,title,long_url,short_url
Benzinga,GeneTx Bio-Ultragenyx's Angelman Syndrome Study To Start Enrollment In Canada,https://benzinga.com/general/biotech/21/05/21197241/genetx-bio-ultragenyxs-angelman-syndrome-study-to-start-enrollment-in-canada,https://j.mp/3bWZ8Z1
Benzinga,"Additional Assay Data Holdup Delays Iovance's Lifileucel Filing Again, CEO Resigns; Shares Plunge",https://benzinga.com/general/biotech/21/05/21201819/additional-assay-data-holdup-delays-iovances-lifileucel-filing-again-ceo-resigns-shares-plunge,https://j.mp/2RzPsfL
